MLYS Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline SBEV Q2 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges LOW Q1 2026 Earnings Earnings Beat Estimates as Consumer Caution Weighs on Shares